Propolis can Potentially Prevent SARS-CoV-2 from Binding to ACE2
Multiple compounds found in propolis-ruin and myricetin, hesperidia, chrysin and pinocembrin, and caffein acid, p-coumaric acid, and t-cinncamic acid were tested fro their ability to bind to ACE2. Through molecular docking evaluations, It was found that rutin was the most effective compound at binding to ACE2. This means propolis could potentially function as an ACE2 inhibitor, and prevent SARS-CoV-2 from binding to the ACE2 receptor.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Propolis leads to reduction of pro-inflammatory cytokines
Propolis is an effective adjuvant therapy for multiple COVID-19 patient comorbidities
Propolis Interacts with the Main Protease of SARS-CoV-2
Propolis can Potentially Prevent SARS-CoV-2 from Binding to ACE2
The potential for kaempferol in propolis to treat COVID-19
Propolis blocks PAK-1 and and can contributes to alleviation of COVID-19 symptoms
Immunostimulatory Properties of Propolis
Propolis as a Potential COVID-19 Vaccine Adjuvant
Propolis Administration for COVID-19 Treatment and Prevention